Artrial hypertension is a very serious social-medical probleme as such has an epidemic characteristics according to high prevalence at incidence frequency disease of young, a high death rate, there is also a somewhat difficult erly diagnosis at the early stages of illnes due to unspecified clinical examination in majority of diseased. On the basis of etiology, arterial hypertension is divived into: primary (essential) and secondary (symptomatologic). According to the current criteria, primary arterial hypertension is considered to be all the cases where etiology cannot identify only the cause or a specific structural change in a organ. It instead causes a larger number of etiological factors by their group actions which are called risk factors.Including the secondary hypertension all cases at arterial hypertension are classified und there can be seen a specific structural change in an organ and disorder of it's function. The aim of our work was to determinate which were the familiar risk factors in development of arterial hypertension and it's domination to inhabitants of Zubin Potok considering high prevalence of arterial hypertension out of 6500 inhabitants in the infirmary of Zubin Potok, 2450 patients are registrated with arterial hypertension. Examination is performed to 100 patients with primary arterial hypertension by prospectus analysis which are registrated consecutively in the interval of two months by biochemicals parametars, a height of systolic and dyastolic arterial pressure and BMI. By means of questionnaire the rest of risk factors are gathered with a piece of data smoking, alchoholism and stress. During the examination we determined that the most typics risk factor is disorder of metabolism of lypoproteins, and important pathothysiological mechanism in development of arterial hypertension is reduction of HDLcholesterol, which can be one of indirect indentifier of oxidative stress.
Lima CT, Carvalho FM, Quadros Cde A. Arterial hypertension and alcoholism among workers in an oil refinery. Rev Panam Salud Publica. 6(3):185–91.
3.
Lin JX, Yang X, Zheng XY, Chen DG. Endothelial dysfunction and target organ damage in hypertensive patients complicating with or without metabolic syndrome. Zhonghua Xin Xue Guan Bing Za Zhi. 35(8):710–4.
4.
Lucas DL, Brown RA, Wassef M, Giles TD. Alcohol and the cardiovascular system: Research challenges and opportunities. J Am Coll Cardiol. 45(12):1916–24.
5.
Luis M, Ruilope MD, Manuel Luque MD. Glucose metabolism in patients with essential hypertension. Am J Med. 119(4):318–26.
6.
Miller PM, Anton RF, Egan BM. Excessive alcohol consumption and hypertension: Clinical implications of current research. J Clin Hypertens (Greenwich. 7(6):346–51.
7.
Mitić R, Tomić Z. Interakcije lekova i uticaj lekova na laboratorijske analize. II izdanje Medicinski fakultet Priština.
8.
Mujović VM. Fakori rizika i homeostaza.
9.
Mujović VM. Homeostaza i telesne tečnosti. Elit Medica, drugo izdanje. :390–1.
10.
Nedeljković IS, Kanjuh V, Kardiologija VM. Medicinski fakultet.
11.
Oyama N, Sakuma I, Kishimoto. Low HDL-cholesterol, hypertension, and impaired glucose tolerance as predictors of acute myocardial infarction in the northern area of Japan. Hokkaido Igaku Zasshi. 81(1):25–30.
12.
Kunitomo M. Oxidative stress and atherosclerosis. Yakugaku Zasshi. 127(12):1997–2014.
13.
Parikh NI, Pencina MJ, Wang TJ. A risk score for predicting near-term incidence of hypertension: The Framingham Heart Study. Ann Intern Med. 148(2):102–10.
14.
Lj P. Preporučeni dnevni unos namirnica.
15.
Schutte AE, Rooyen JM, Huisman HW. Factor analysis of possible risks for hypertension in a black South African population. J Hum Hypertens. 17(5):339–48.
16.
Shenouda SM, Vita JA. Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr. 26(4):366–72.
17.
CU SW, K NB, JN M. Risk factors and complications of hypertension in Yaoundé, Cameroon. Cardiovasc J S Afr. 15(5):215–9.
18.
Sun Z, Zheng L, Xu C. Prevalence of prehypertension, hypertension, and associated risk factors in Mongolian and Han Chinese populations in Northeast China. Int J Cardiol.
19.
Takata Y, Osawa H, Kurata M. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension.
20.
Tseng CH. Body mass index and blood pressure in adult type 2 diabetic patients in Taiwan. Circ J. 71(11):1749–54.
21.
Žigić D, Konstantinović D, Dragica A. Arterijska hipertenzija i hipotenzija. :126–7.
22.
Đorđević V. Hipertenzija: dijagnoza i lečenje.
23.
Allison MA, Lillie EO, Tomasso D. Renal artery calcium is independently associated with hypertension. J Am Coll Cardiol. 50(16):1578–83.
24.
Arterijska hipertenzija - Nacionalni vodič za lekare u primarnoj zdravstvenoj zaštiti.
25.
Bär KJ, Boettger MK, Boettger S. Reduced baroreflex sensitivity in acute alcohol withdrawal syndrome and in abstained alcoholics. Drug Alcohol Depend. 85(1):66–74.
26.
Bhattacharyya S, Mukhopadhyay M, Bhattacharyya I. A study on body mass index (BMI) and some biochemical parameters of the medicos with family history of diabetes mellitus, hypertension, and coronary heart disease. J Indian Med Assoc. 105(7):374.
27.
Bowman TS, Gaziano JM, Buring JE, Sesso HD. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol. 50(21):2085–92.
28.
Byeon YS, Lee HS. Relation of the blood pressure, lipids, and body mass index by smoking status among adolescents. Taehan Kanho Hakhoe Chi. 37(6):1020–6.
29.
Ceccanti M, Sasso GF, Nocente R. Hypertension in early alcohol withdrawal in chronic alcoholics. Alcohol. 41(1):5–10.
30.
Cheung BM, Wat NM, Man YB. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2. Am J Hypertens. 21(1):17–22.
31.
Cizek SM, Bedri S, Talusan P. Risk factors for atherosclerosis and the development of preatherosclerotic intimal hyperplasia. Cardiovasc Pathol. 16(6):344–50.
32.
Dost A, Klinkert C, Kapellen T. Arterial hypertension determined by ambulatory blood pressure profiles: Contribution to microalbuminuria risk in a multicenter investigation in 2105 children and adolescents with diabetes mellitus type 1. Diabetes Care.
33.
Alexander LM. Hypertension within the cardiovascular disease risk paradigm. JAAPA. Suppl:3–8.
34.
Gupta R, Sarna M, Thanvi J. Fasting glucose and cardiovascular risk factors in an urban population. J Assoc Physicians India. 55:705–9.
35.
Gu D, Kelly TN, Wu X. Blood pressure and risk of cardiovascular disease in Chinese men and women. Am J Hypertens.
36.
Harrison TR. Osnovni principi interne medicine.
37.
Huntgeburth M, Ten Freyhaus H, Rosenkranz S. Alcohol consumption and hypertension. Curr Hypertens Rep. 7(3):180–5.
38.
Irwin MR, Ziegler M. Sleep deprivation potentiates activation of cardiovascular and catecholamine responses in abstinent alcoholics. Hypertension. 45(2):252–7.
39.
Ishrana i šećerna bolest. II međunarodna konferencija Zbornik radova. :61–71.
40.
Jovanović J, Jovanović M. Blood pressure, heart rate, and lipids in professional handball and water polo players. Medicinski pregled Beograd. 58(3–4):168–74.
41.
Kardiovaskularne bolesti i ishrana. I međunarodna konferencija Zbornik radova.
42.
Khatibi A, Agardh CD, Nyberg P. Blood pressure in middle-aged women: Are androgens involved? A population-based study of Swedish women: The Women’s Health in the Lund Area study. J Hypertens. 25(10):2044–50.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
